16:29 PMHologic (HOLX): FQ4 EPS of $0.28 beats by $0.01. Revenue of $403M (-9%) vs. $400M. Sees Q1 EPS of $0.24-0.26 vs. $0.30 on revenue of $400M-405M vs. $414M, and full-year EPS of $1.15-1.19 vs. $1.24, on revenue of $1.625B-1.65B vs. $1.69B. Shares -6.7% AH. (PR)
Comment!
16:13 PMHologic (HOLX): FQ3 EPS of $0.29 beats by $0.03. Revenue of $403M (-6%) vs. $395M. Sees full-year EPS of $1.14-1.16 vs. $1.12. Shares -0.7% AH. (PR)
Comment!
18:13 PMHologic (HOLX): FQ2 EPS of $0.29 beats by $0.02. Revenue of $402M (-6.7%) vs. $405M. Sees FQ3 EPS in-line, and revenue of $390-400M vs. $409M consensus. Shares -14.5% AH. (PR)
Comment!
17:09 PMHologic (HOLX): FQ1 EPS of $0.31 beats by $0.02. Revenue of $429M in-line. Sees FQ2 EPS of $0.26-0.28 vs. $0.29 and revenue of $400-410M vs. $435M. Shares -4.8%. (PR)
Comment!
09:22 AMHologic (HOLX): Sees FQ1 EPS of $0.30-0.31 vs. consensus of $0.29, despite lowering its revenue outlook by 3%. "Hologic's balance sheet remains very strong," COO Rob Cascella says. Shares +11% premarket. (PR)
Comment!